Itron (Nasdaq: ITRI ) is expected to report Q4 earnings on Feb. 13. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Itron's revenues will wane -26.6% and EPS will contract -44.5%.
The average estimate for revenue is $471.6 million. On the bottom line, the average EPS estimate is $0.66.
Last quarter, Itron reported revenue of $504.1 million. GAAP reported sales were 18% lower than the prior-year quarter's $615.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.97. GAAP EPS were $0.89 for Q3 against -$12.70 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 34.1%, 530 basis points better than the prior-year quarter. Operating margin was 8.1%, 90 basis points better than the prior-year quarter. Net margin was 7.0%, 9,100 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $2.13 billion. The average EPS estimate is $3.69.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 517 members out of 540 rating the stock outperform, and 23 members rating it underperform. Among 141 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 135 give Itron a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Itron is outperform, with an average price target of $49.34.
Looking for alternatives to Itron? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Itron to My Watchlist.